Learn More About FDA Ruling that IQOS is Modified Risk

It took more than 3 years for the United States Food and Drug Administration (FDA) to complete their review of IQOS and determine whether it would be considered a modified risk tobacco product (MTRP). Today Philip Morris International (PMI), the maker of IQOS, released a comprehensive overview of that review process, including a detailed examination of legal requirements and assessment tools like studies and post-market surveillance.

To read the full Scientific Review, click here.

SOURCE: https://www.pmi.com/media-center/press-releases/press-details/?newsId=22826